CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical investigation to move promising concepts toward potential patient impact.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.
Impact Grant - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology projects to explore new immunotherapy approaches and accelerate research in this disease.